Pharmacovigilance platform · OnePV

One platform for modern pharmacovigilance.

Signal Automation and Literature Monitoring in one governed workspace — reviewer-controlled, automated where it counts, audit-ready by design.

✓ Reviewer-controlled✓ Audit-ready by design✓ Human-in-the-loop
OnePV· Acme PharmaAK
Signal lifecycle board2026-Q2 · last run 06:12
Live · 5 active signals
HIGH
Brevanta
Hepatic injury · 1 case
ROR 4.83
new
MED
Caldyra
QT prolongation · assessing
PRR 2.91
due 2d
CLOSED
Tovaris
Nausea · not a signal
closed 4d
Every stage transition is reviewer-gated and written to the audit trail.
Built forMAHsCROsPV teamsSignal review committees
Automation

Put the pharmacovigilance busywork on autopilot.

Vigicore automates the mechanical steps end to end — intake, coding, scoring, drafting, and the audit trail — so your reviewers spend their time on judgment, not data wrangling.

1Auto
Multi-channel intake
2Auto
MedDRA coding
3Auto
Disproportionality
4Auto
E2B(R3) drafting
5Auto
Audit trail
● Automated

Multi-channel intake

Case data, PubMed, journals and dictionaries flow in on a schedule — no inbox triage, no manual uploads.

Email · S3 · PubMed · Journals
● Automated

MedDRA coding

Reactions auto-coded to PT and rolled up to SOC from the shared, version-stamped dictionary.

PT · SOC roll-up
● Automated

Disproportionality at scale

PRR, ROR, EBGM and IC computed across every drug–event pair — every run, automatically.

PRR · ROR · EBGM · IC
● Automated

Deterministic triage

Explainable scoring surfaces the literature that matters and lets the noise fall away.

Transparent · self-learning
● Automated

E2B(R3) drafting

Qualifying cases assembled into structured, submission-ready draft packages.

ICSR · E2B(R3)
● Automated

Continuous audit trail

Intake, coding, calculations, decisions and sign-off are written to an append-only trail as they happen.

Append-only · inspection-ready

Automated where it's mechanical — reviewer-controlled where it counts. Vigicore never draws automatic causality conclusions.

The OnePV platform

Two apps. One identity, one dictionary, one audit trail.

Purpose-built apps on shared foundations — so teams move between detection, evidence, literature, and documentation without losing control.

01

One sign-in

A single, MFA-protected OnePV identity opens every app. One account, one session across the suite.

02

One MedDRA dictionary

A shared, version-stamped MedDRA dictionary powers coding and SOC roll-up consistently across all apps.

03

Tenant-scoped & role-based

Multi-client operating model with role-based access — built for MAHs, CROs, and PV service providers.

04

One audit trail

Human-readable, append-only audit history across detection, review, and documentation.

APP 01

Signal Automation

Disproportionality detection, evidence review, a persistent signal register, and Signal Evaluation Report drafting — under reviewer control.

  • PRR · ROR · EBGM · IC scoring
  • MedDRA hierarchy & SMQ grouping
  • Signal lifecycle register
  • Guardian-assisted SER drafting
Explore Signal Automation →
APP 02

Literature Monitoring

Consolidated PubMed and journal surveillance with deterministic, explainable triage and structured ICSR / E2B(R3) drafting support.

  • PubMed + local journal scanning
  • Deterministic, self-learning triage
  • MedDRA coding (PT / SOC)
  • ICSR / E2B(R3) drafting support
Explore Literature Monitoring →
Inside the platform

See the workspace your reviewers work in.

Structured capture, transparent analysis, a qualified-reviewer gate, and a permanent, inspectable record — the same governed flow across both apps.

OnePV· Acme Pharma
Signals 5Literature 18Reports Audit
Signals › Lifecycle board
Signal lifecycle board
Live · 2026-Q2 data cut · last run 06:12
Detected · 2
BrevantaHIGH
Hepatic injury · 1 case
ROR 4.83unassigned · new
SondaraMED
Rhabdomyolysis · 2 cases
ROR 3.62unassigned · 3h
Validated · 1
Orvexa
Pancytopenia · 8 cases
EBGM 3.11AK · due 5d
Assessing · 1
Caldyra
QT prolongation · 2 cases
PRR 2.91MK · due 2d
Closed · 1
Tovaris
Nausea · 9 cases
Not a signalclosed 4d
Every stage transition is reviewer-gated and written to the append-only audit trail.
01

Capture

Case data, literature, and the shared MedDRA dictionary land in one governed workspace.

02

Analyze

Disproportionality and deterministic triage surface what needs attention — transparently.

03

Reviewer control

Every flagged item is gated by a qualified reviewer. No automatic causality, no black box.

04

Audit-ready record

Decisions, evidence, and rationale persist in an append-only history, ready for inspection.

Why Vigicore

Built for control, traceability, and trust.

Vigicore is designed for reviewer-facing transparency — not black-box conclusions.

Reviewer-controlled

Decisions stay with people. Vigicore surfaces evidence and structure — it does not draw automatic causality conclusions.

Validated calculation logic

Transparent, documented statistical methods aligned to recognised disproportionality approaches.

Audit-ready by design

Traceable, append-only history so every step of the review can be reconstructed.

Human-in-the-loop

Designed around the reviewer journey — from output to interpretation to documentation to sign-off.

Enterprise multi-tenant

Role-based access and per-client isolation for portfolios and repeated data cuts.

Evidence-bound Guardian

Drafting support is tied to gathered evidence and stays under reviewer control.

Global & local coverage

Designed to fit how PV teams work across major and regional authorities — automating MedDRA coding, E2B(R3) drafting support, and audit-ready records, with reviewers in control of every decision.

FDA · USEMA · EUMHRA · UKNMPA · ChinaEastern EuropeIndiaGulf · GCCRegional authorities
Get in touch

Request a demo, a pilot, or an investment conversation.

Tell us about your team, portfolio, or partnership interest and we'll follow up with the right next step — a guided walkthrough, a scoped pilot, or a founder conversation.

Seeking investment

Signal Automation and Literature Monitoring are live and growing. We're seeking strategic investment and enterprise partnerships to scale OnePV.

Read the investment story →
0 / 20 min

We respond to qualified PV, enterprise, and investment enquiries.